Discontinued — last reported Q3 '16
An increase signals a decline in the expected value of intellectual property or market position, which is generally negative.
Measures the write-down of the carrying value of non-goodwill intangible assets, such as patents, trademarks, or acquire...
Comparable to 'intangible asset impairment' charges reported by other R&D-heavy pharmaceutical companies.
zts_segment_material_reconciling_items_impairment_of_intangible_assets_excluding_goodwill